Publications by authors named "Eric Wold"

Claim this Profile
A
A Virulence Inhibitor Identified by SaeRS Refactoring and Screening in .
Felix Ekness, Eric A Wold, Catherine S Leasure, Elena Musteata, Andrew J Monteith

ACS Synth Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT Receptor and Dual 5-HT/5-HT Receptor Modulators.
Jianping Chen, Erik J Garcia, Christina R Merritt, Joshua C Zamora, Andrew A Bolinger, Eric A Wold

J Med Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site.
Zhiqing Liu, Yi Li, Haiying Chen, Hsien-Tsung Lai, Pingyuan Wang, Eric A Wold

J Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential impact of mammographic breast arterial calcification on physician practices in a primary care setting.
Melissa Gennarelli, Andrzej Jedynak, Leanne Forman, Eric Wold, Rebecca B Newman

Future Cardiol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.
Zhiqing Liu, Pingyuan Wang, Eric A Wold, Qiaoling Song, Chenyang Zhao

J Med Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome.
Jimin Xu, Judith Berastegui-Cabrera, Marta Carretero-Ledesma, Haiying Chen, Yu Xue, Eric A Wold

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A Wold

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties.
Eric A Wold, Erik J Garcia, Christopher T Wild, Joanna M Miszkiel, Claudia A Soto

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation.
Zhiqing Liu, Haiying Chen, Pingyuan Wang, Yi Li, Eric A Wold

J Med Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
Eric A Wold, Christopher T Wild, Kathryn A Cunningham, Jia Zhou

Curr Top Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of Bioorthogonal Chemistry in Tumor-Targeted Drug Discovery.
Gang Liu, Eric A Wold, Jia Zhou

Curr Top Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer.
Gang Liu, Tao Yin, Hyejin Kim, Chunyong Ding, Zhuo Yu, Eric A Wold

Eur J Med Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT Receptor.
Christopher T Wild, Joanna M Miszkiel, Eric A Wold, Claudia A Soto, Chunyong Ding

J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
Eric A Wold, Jianping Chen, Kathryn A Cunningham, Jia Zhou

J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.
Na Ye, Bang Li, Qi Mao, Eric A Wold, Sheng Tian

ACS Chem Neurosci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications.
Eric A Wold, Jia Zhou

Curr Top Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads.
Ye Ding, Dengfeng Li, Chunyong Ding, Pingyuan Wang, Zhiqing Liu, Eric A Wold

J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection.
Jimin Xu, Eric A Wold, Ye Ding, Qiang Shen, Jia Zhou

Molecules· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Discovery Targeting Bromodomain-Containing Protein 4.
Zhiqing Liu, Pingyuan Wang, Haiying Chen, Eric A Wold, Bing Tian

J Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of natural product oridonin-inspired anticancer agents.
Ye Ding, Chunyong Ding, Na Ye, Zhiqing Liu, Eric A Wold

Eur J Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inorganic Arsenic-Related Changes in the Stromal Tumor Microenvironment in a Prostate Cancer Cell-Conditioned Media Model.
Joseph J Shearer, Eric A Wold, Charles S Umbaugh, Cheryl F Lichti, Carol L Nilsson

Environ Health Perspect· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BH4 domain of Bcl-2 as a novel target for cancer therapy.
Zhiqing Liu, Christopher Wild, Ye Ding, Na Ye, Haiying Chen, Eric A Wold

Drug Discov Today· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Na Ye, Haiying Chen, Eric A Wold, Pei-Yong Shi, Jia Zhou

ACS Infect Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile physician reporting of clinically significant events-a novel way to improve handoff communication and supervision of resident on call activities.
Christopher Nabors, Stephen J Peterson, Wilbert S Aronow, Sachin Sule, Arif Mumtaz, Eric Wold

J Patient Saf· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with faculty supervision of an electronic resident sign-out system.
Christopher Nabors, Stephen J Peterson, Wei-Nchih Lee, Arif Mumtaz, Tushar Shah, Eric Wold

Am J Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis